Crossmark Global Holdings’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-9,237
| Closed | -$392K | – | 1327 |
|
|
2023
Q2 | $392K | Sell |
9,237
-211
| -2% | -$8.95K | 0.01% | 950 |
|
|
2023
Q1 | $336K | Buy |
9,448
+69
| +0.7% | +$2.45K | 0.01% | 998 |
|
|
2022
Q4 | $344K | Sell |
9,379
-701
| -7% | -$25.7K | 0.01% | 961 |
|
|
2022
Q3 | $475K | Sell |
10,080
-110
| -1% | -$5.18K | 0.01% | 789 |
|
|
2022
Q2 | $731K | Sell |
10,190
-60
| -0.6% | -$4.3K | 0.02% | 663 |
|
|
2022
Q1 | $830K | Buy |
10,250
+250
| +3% | +$20.2K | 0.02% | 693 |
|
|
2021
Q4 | $1.03M | Sell |
10,000
-4,170
| -29% | -$428K | 0.02% | 620 |
|
|
2021
Q3 | $1.24M | Buy |
14,170
+220
| +2% | +$19.3K | 0.03% | 545 |
|
|
2021
Q2 | $1.25M | Buy |
13,950
+1,040
| +8% | +$93K | 0.03% | 538 |
|
|
2021
Q1 | $979K | Buy |
12,910
+820
| +7% | +$62.2K | 0.02% | 603 |
|
|
2020
Q4 | $824K | Buy |
12,090
+3,420
| +39% | +$233K | 0.02% | 629 |
|
|
2020
Q3 | $461K | Buy |
8,670
+50
| +0.6% | +$2.66K | 0.01% | 804 |
|
|
2020
Q2 | $502K | Buy |
8,620
+800
| +10% | +$46.6K | 0.01% | 754 |
|
|
2020
Q1 | $308K | Sell |
7,820
-20
| -0.3% | -$788 | 0.01% | 832 |
|
|
2019
Q4 | $466K | Buy |
7,840
+2,560
| +48% | +$152K | 0.01% | 837 |
|
|
2019
Q3 | $281K | Sell |
5,280
-180
| -3% | -$9.58K | 0.01% | 1088 |
|
|
2019
Q2 | $279K | Sell |
5,460
-160
| -3% | -$8.18K | 0.01% | 1134 |
|
|
2019
Q1 | $291K | Sell |
5,620
-40
| -0.7% | -$2.07K | 0.01% | 1141 |
|
|
2018
Q4 | $223K | Buy |
5,660
+240
| +4% | +$9.46K | 0.01% | 1243 |
|
|
2018
Q3 | $279K | Buy |
5,420
+170
| +3% | +$8.75K | 0.01% | 1368 |
|
|
2018
Q2 | $246K | Buy |
+5,250
| New | +$246K | 0.01% | 1435 |
|
|
2018
Q1 | – | Sell |
-5,350
| Closed | -$233K | – | 1638 |
|
|
2017
Q4 | $233K | Sell |
5,350
-3,230
| -38% | -$141K | 0.01% | 1517 |
|
|
2017
Q3 | $449K | Buy |
+8,580
| New | +$449K | 0.01% | 1030 |
|
|
2016
Q3 | $449K | Buy |
+8,580
| New | +$449K | 0.01% | 1030 |
|